Legal & General Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129M Buy
787,079
+246,766
+46% +$37.9M 0.03% 453
2025
Q4
$94M Buy
540,313
+332,292
+160% +$60.6M 0.02% 528
2025
Q3
$30M Buy
208,021
+170
+0.1% +$20.8K 0.01% 728
2025
Q2
$20.9M Buy
207,851
+27,649
+15% +$2.11M 0.01% 833
2025
Q1
$13.7M Buy
180,202
+4,188
+2% +$320K ﹤0.01% 973
2024
Q4
$12.2M Buy
176,014
+14,246
+9% +$1.03M ﹤0.01% 1077
2024
Q3
$11.8M Buy
161,768
+12,205
+8% +$901K ﹤0.01% 1088
2024
Q2
$10M Buy
149,563
+7,739
+5% +$300K ﹤0.01% 1131
2024
Q1
$3.85M Buy
141,824
+346
+0.2% +$9.68K ﹤0.01% 1644
2023
Q4
$4.38M Buy
141,478
+6,824
+5% +$177K ﹤0.01% 1584
2023
Q3
$3.4M Buy
134,654
+1,082
+0.8% +$24.7K ﹤0.01% 1651
2023
Q2
$2.82M Buy
133,572
+1,673
+1% +$31.7K ﹤0.01% 1757
2023
Q1
$2.25M Buy
131,899
+7,965
+6% +$155K ﹤0.01% 1836
2022
Q4
$2.48M Buy
123,934
+17,428
+16% +$337K ﹤0.01% 1784
2022
Q3
$2.29M Sell
106,506
-9,040
-8% -$217K ﹤0.01% 1793
2022
Q2
$2.28M Sell
115,546
-7,383
-6% -$155K ﹤0.01% 1825
2022
Q1
$2.89M Buy
122,929
+16,249
+15% +$378K ﹤0.01% 1816
2021
Q4
$2.91M Buy
106,680
+1,364
+1% +$39K ﹤0.01% 1846
2021
Q3
$2.9M Buy
105,316
+30,215
+40% +$793K ﹤0.01% 1842
2021
Q2
$2.14M Buy
75,101
+82
+0.1% +$2.43K ﹤0.01% 1937
2021
Q1
$2.56M Buy
75,019
+562
+0.8% +$21.5K ﹤0.01% 1870
2020
Q4
$2.48M Sell
74,457
-244
-0.3% -$8.91K ﹤0.01% 1795
2020
Q3
$2.4M Buy
74,701
+6,870
+10% +$197K ﹤0.01% 1688
2020
Q2
$1.87M Buy
67,831
+13,577
+25% +$322K ﹤0.01% 1758
2020
Q1
$870K Sell
54,254
-2,227
-4% -$52.8K ﹤0.01% 1892
2019
Q4
$1.35M Buy
56,481
+11,965
+27% +$243K ﹤0.01% 1957
2019
Q3
$785K Buy
44,516
+4,243
+11% +$81.9K ﹤0.01% 2072
2019
Q2
$1.03M Buy
40,273
+500
+1% +$13.9K ﹤0.01% 1948
2019
Q1
$1.16M Buy
39,773
+10,437
+36% +$270K ﹤0.01% 1920
2018
Q4
$385K Buy
29,336
+1,263
+4% +$20.2K ﹤0.01% 2173
2018
Q3
$568K Hold
28,073
﹤0.01% 2107
2018
Q2
$664K Sell
28,073
-1,584
-5% -$40.8K ﹤0.01% 2044
2018
Q1
$668K Sell
29,657
-5,009
-14% -$132K ﹤0.01% 2040
2017
Q4
$1.08M Buy
34,666
+2,996
+9% +$88.5K ﹤0.01% 1860
2017
Q3
$984K Buy
31,670
+11,497
+57% +$219K ﹤0.01% 1871
2017
Q2
$347K Buy
20,173
+390
+2% +$6.66K ﹤0.01% 2138
2017
Q1
$344K Sell
19,783
-213
-1% -$3.29K ﹤0.01% 2118
2016
Q4
$265K Buy
19,996
+6,408
+47% +$87.4K ﹤0.01% 2144
2016
Q3
$192K Sell
13,588
-701
-5% -$8.78K ﹤0.01% 2037
2016
Q2
$140K Hold
14,289
﹤0.01% 1923
2016
Q1
$182K Buy
14,289
+959
+7% +$12.6K ﹤0.01% 1771
2015
Q4
$244K Hold
13,330
﹤0.01% 1669
2015
Q3
$242K Buy
13,330
+5,121
+62% +$128K ﹤0.01% 1614
2015
Q2
$196K Buy
8,209
+2,166
+36% +$49.2K ﹤0.01% 1757
2015
Q1
$127K Hold
6,043
﹤0.01% 1885
2014
Q4
$94K Hold
6,043
﹤0.01% 2021
2014
Q3
$79K Buy
+6,043
New +$91.1K ﹤0.01% 2068

Other funds holding INSM

Legal & General Group's INSM Position: Q1 2026 in Review

Legal & General Group increased its Insmed (INSM) stake by 46% in Q1 2026, buying an estimated $37.9M and bringing the position to 787,079 shares worth $129M. The position accounts for 0.03% of the portfolio, ranked #453.

Legal & General Group first reported a position in INSM in Q3 2014 and has held it in 47 quarters since. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Legal & General Group held 787,079 shares of Insmed worth $129M as of Q1 2026.
  • Legal & General Group bought 246,766 Insmed shares in Q1 2026, an estimated $37.9M.
  • Insmed made up 0.03% of Legal & General Group's portfolio in Q1 2026, its #453 holding.
  • Legal & General Group first reported a position in Insmed in Q3 2014 and has held it in 47 quarters since.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.